Overcoming Chemotherapy Resistance in Refractory Multiple Myeloma With Simvastatin, A Pilot Study

Trial Profile

Overcoming Chemotherapy Resistance in Refractory Multiple Myeloma With Simvastatin, A Pilot Study

Withdrawn prior to enrolment
Phase of Trial: Phase I

Latest Information Update: 12 May 2017

At a glance

  • Drugs Simvastatin (Primary)
  • Indications Multiple myeloma
  • Focus Therapeutic Use
  • Most Recent Events

    • 08 May 2017 Status changed from not yet recruiting to withdrawn prior to enrolment.
    • 20 Feb 2017 Planned initiation date changed from 1 Nov 2016 to 1 Apr 2017.
    • 25 Nov 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top